A single-center, double-blind, randomized, controlled trial for Calcium oxybenzosulfonate dispersible tablets in the treatment of postoperative prepuce edema

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023633

Enrollment

Unknown

Registered

2019-06-04

Start date

2019-06-10

Completion date

Unknown

Last updated

2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

redundant prepuce

Interventions

Experimental group:calcium oxybenzosulfonate dispersible tablets

Control group:Placebo

Eligibility

Sex/Gender

Male

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The prepuce covers the entire head of the penis and the external orifice of the urethra; 2. foreskin can turn up and expose the penis head; 3. Read and sign the informed consent for surgical treatment; 4. At least 18 years of age.

Exclusion criteria

Exclusion criteria: 1. foreskin and glans penis deformity; 2. combined with urinary tract infection; 3. foreskin glans; 4. foreskin plate and penis head adhesion serious; 5. patients with underlying diseases that may affect surgical efficacy, such as combined coagulation dysfunction and diabetes.

Design outcomes

Primary

Measure	Time frame
Degree of postoperative foreskin swelling;	—

Countries

China

Contacts

Public ContactZhou Tie

Shanghai Changhai Hospital

wenzhoutie80@yahoo.com+86 13918360523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026